Author/Authors :
Malekzadeh Reza نويسنده , Zali Mohammadreza نويسنده , Rostami Kamran نويسنده Department of Gastroenterology, Mid Staffordshire NHS Foundation Trust, Stafford , Rostami Nejad .M نويسنده Research Institute for Gastroenterology and Liver Diseases - Shahid Beheshti University of Medical Sciences , Emami MohammadHasan نويسنده Poursina Hakim Research Institute (PHRI) - Isfahan University of Medical Sciences (IUMS)
Abstract :
Celiac disease (CD) was traditionally believed to be a chronic
enteropathy, almost exclusively affecting people of European
origin. Celiac disease is the permanent intolerance to dietary
gluten, the major protein component of wheat. The availability
of new, simple, very sensitive and specific serological tests has
shown that CD is as common in Middle Eastern countries as in
Europe, Australia and New Zealand where the major dietary staple
is wheat. A high prevalence of CD has been found in Iran, in both
the general population and the at-risk groups, i.e. patients with
type 1 diabetes or irritable bowel syndrome (IBS).
In developing countries, serological testing in at risk groups
is necessary for early identification of celiac patients. Clinical
studies show that presentation with non-specific symptoms or a
lack of symptoms is as common in the Middle East as in Europe.
Wheat is a major component of the Iranian diet and exposure to
wheat proteins induces some degree of immune tolerance, leading to milder symptoms that may be mistaken with other GI disorders. The implementation of gluten free diet (GFD) is a major
challenge for both patients and clinicians in Iran, especially since
commercial gluten-free products are not available in this area.